Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
869.2 INR | +2.82% |
|
-2.14% | +14.45% |
06-18 | Alembic Pharmaceuticals Gets US FDA Nod for Dabigatran Etexilate Capsules | MT |
06-17 | Alembic Pharmaceuticals Gets US FDA's Final Approval for Generic Drug Angioedema | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.45% | 2.04B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- APLLTD Stock
- News Alembic Pharmaceuticals Limited
- Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets